share_log

Biomea Fusion Stock Down 48% But Insiders Still In US$17k Profit

Biomea Fusion Stock Down 48% But Insiders Still In US$17k Profit

Biomea Fusion公司股價下跌48%,但內部人員仍獲得1.7萬美元的利潤。
Simply Wall St ·  06/14 20:44

Biomea Fusion, Inc. (NASDAQ:BMEA) insiders who acquired shares over the previous 12 months, can probably afford to ignore the recent 48% decline in the stock price. After taking the recent loss into consideration, the US$55.4k worth of stock they bought is now worth US$72.7k, indicating that their investment yielded a positive return.

過去12個月裏購買了Biomea Fusion,Inc. (納斯達克:BMEA)股票的內部人員可能可以無視最近48%的股價下跌。考慮到最近的虧損,他們購買的價值爲55.4萬美元的股票現在價值爲72.7萬美元,表明他們的投資帶來了正面回報。

While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we do think it is perfectly logical to keep tabs on what insiders are doing.

雖然我們絕不建議投資者僅基於公司董事所做的事情來作出決策,但我們認爲密切關注內部人士所做的事情是完全合理的。

The Last 12 Months Of Insider Transactions At Biomea Fusion

Biomea Fusion公司內部交易的最後12個月

Notably, that recent purchase by Franco Valle is the biggest insider purchase of Biomea Fusion shares that we've seen in the last year. Even though the purchase was made at a significantly lower price than the recent price (US$5.81), we still think insider buying is a positive. Because the shares were purchased at a lower price, this particular buy doesn't tell us much about how insiders feel about the current share price.

值得注意的是,Franco Valle最近的購買是我們在過去一年裏看到的Biomea Fusion股票最大的內部人員購買。儘管購買價比最近的價格低得多(5.81美元),我們仍認爲內部購買是一個積極的信號。因爲這些股票是以較低的價格購買的,所以這次購買並不能告訴我們內部人員對目前股價的看法。

You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. By clicking on the graph below, you can see the precise details of each insider transaction!

您可以在下面的圖表中查看過去一年(由公司和個人)的內部交易。通過單擊下面的圖表,您可以查看每個內部交易的詳細信息!

insider-trading-volume
NasdaqGS:BMEA Insider Trading Volume June 14th 2024
NasdaqGS:BMEA內部交易成交量2024年6月14日

Biomea Fusion is not the only stock that insiders are buying. For those who like to find small cap companies at attractive valuations, this free list of growing companies with recent insider purchasing, could be just the ticket.

Biomea Fusion並不是唯一一家內部人員正在購買股票的公司。對於那些希望以有吸引力的估值找到小盤公司的人來說,這個免費的增長股清單(最近有內部人員購買)可能會是一張好牌。

Does Biomea Fusion Boast High Insider Ownership?

Biomea Fusion的內部人員持股高嗎?

Many investors like to check how much of a company is owned by insiders. We usually like to see fairly high levels of insider ownership. Biomea Fusion insiders own about US$27m worth of shares. That equates to 13% of the company. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.

許多投資者喜歡查看公司受內部人員持有的股份比例,我們通常喜歡看到較高水平的內部人員持股。Biomea Fusion內部人員持有大約價值2700萬美元的股份,相當於該公司的13%。雖然這是一個強,但不是非常突出的內部人員持股水平,但足以表明管理層和小股東之間存在一些一致性。

So What Does This Data Suggest About Biomea Fusion Insiders?

這些數據對Biomea Fusion內部人員有何啓示?

It is good to see the recent insider purchase. We also take confidence from the longer term picture of insider transactions. But we don't feel the same about the fact the company is making losses. Given that insiders also own a fair bit of Biomea Fusion we think they are probably pretty confident of a bright future. While it's good to be aware of what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. Case in point: We've spotted 3 warning signs for Biomea Fusion you should be aware of, and 2 of them are significant.

很高興看到最近有內部人員購買股票。長期來看,內部交易的情況也讓我們有信心。但我們對公司虧損的事實並不感到滿意。鑑於內部人員也持有相當數量的Biomea Fusion股票,我們認爲他們對輝煌明天也充滿信心。雖然了解內部人員持股和交易的情況很重要,但在做出任何投資決策之前,我們也要注意看到股票面臨的風險。就此而言:我們已經發現了3個Biomea Fusion的警示信號,您應該留意其中的兩個。

Of course Biomea Fusion may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

當然,Biomea Fusion可能不是最好的投資選擇。所以您可能希望查看這個高品質公司的免費收藏。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

對於本文而言,內部人是指向相關監管機構報告其交易的個人。我們目前僅考慮公開市場交易和直接利益的私人處置,但不包括衍生交易或間接利益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或者,發送電子郵件至editorial-team (at) simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或者發送電子郵件至editorial-team@simplywallst.com。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論